Pure Global
PACTR202310667867616

Comparative evaluation of efficacy of biodentine, mineral trioxide aggregate, calcium hydroxide and glass ionomer cement as pulp capping agent in deep carious lesions

Adamu Abdullahi Biu·Not Applicable·Pan Africa Clinical Trials Registry·otherRecruiting
Study focus
Disease/Condition
Oral Health
Intervention type
other
Sponsor & location
Primary sponsor
Adamu Abdullahi Biu
Funder
self
Location
Nigeria
Timeline & enrollment
Phase
Not Applicable
Start date
Jul 10, 2023
End date
Jan 01, 1900
Summary

The treatment of deep carious lesions (DCLs) aims mainly to maintain the affected dentin on the pulpal floor, and promote formation of new dentine, thus preserving the pulp vitality. Several pulp capping agents have been used with controversial outcomes, leaving clinicians to determine the most satisfactory agent in their practice. The purpose of this study was to clinically and radiographically compare and evaluate four types of indirect pulp capping (IPC) agents used in management of DCLs.

ICD-10 classifications
Diseases of oral cavity, salivary glands and jawsDry mouth, unspecifiedOral mucositis (ulcerative)Leukoplakia and other disturbances of oral epithelium, including tongueTeething syndrome
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202310667867616
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202310667867616 through Pure Global AI's free database. This Not Applicable trial is sponsored by Adamu Abdullahi Biu and is currently Recruiting. The study focuses on Oral Health.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.